Psychiatry and Neurology, Neurology · South Portland, ME
NPI
1730476839
Since 2011
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
5
Medicare group memberships
Hospitals
4
Hospital affiliations
50 Foden Rd
South Portland, ME, 04106
Phone (207) 523-3900
Groups this clinician bills Medicare through
Medicare paid, 2024
$43K
772 services
Medicare patients, 2024
292
Average age 67
Drug cost, 2024
$3.3M
3,571 prescriptions
Company payments, 2025
$7,628
From 15 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Alison C Daigle was code G2211 (visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's), 241 times for 173 patients. In total Alison C Daigle billed 772 services in 20 codes, and Medicare paid $43K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-07-25.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|---|---|---|---|---|
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Facility | 241 | 173 | $11.99 | $2,890 |
| 99214 Office E&M - Established | Facility | 157 | 131 | $68.25 | $11K |
| 99215 Office E&M - Established | Facility | 72 | 60 | $104.20 | $7,502 |
| 99233 Hospital E&M - Subsequent | Facility | 43 | 22 | $88.30 | $3,797 |
| 64615 Musculoskeletal | Facility | 38 | 14 | $89.90 | $3,416 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 35 | 30 | $12.03 | $421 |
| 99222 Hospital E&M - Initial | Facility | 29 | 29 | $96.99 | $2,813 |
| 99205 Office E&M - New | Facility | 27 | 27 | $111.16 | $3,001 |
| 99214 Office E&M - Established | Office | 21 | 18 | $61.19 | $1,285 |
| 99232 Hospital E&M - Subsequent | Facility | 20 | 13 | $61.93 | $1,239 |
| 99204 Office E&M - New | Facility | 16 | 16 | $92.64 | $1,482 |
| 99213 Office E&M - Established | Facility | 12 | 12 | $42.29 | $507 |
| 99223 Hospital E&M - Initial | Facility | 11 | 11 | $136.51 | $1,502 |
By year: 2022 $26K for 331 services; 2023 $33K for 427 services; 2024 $43K for 772 services.
Medicare prescription drug claims, 2024
In 2024, the drug Alison C Daigle prescribed most often to Medicare patients was Gabapentin, with 186 prescriptions and refills. In total Alison C Daigle wrote 3,571 Medicare prescriptions that cost $3.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Gabapentin Generic | 186 | 413 | 61 | $5,913 |
| Baclofen Generic | 165 | 383 | 48 | $5,976 |
| Carbidopa-Levodopa Carbidopa/Levodopa | 145 | 343 | 39 | $3,576 |
| Pregabalin Generic | 131 | 141 | 30 | $3,565 |
| Topiramate Generic | 119 | 235 | 28 | $1,261 |
| Aimovig Autoinjector Erenumab-Aooe | 98 | 104 | 14 | $76K |
| Emgality Pen Galcanezumab-Gnlm | 94 | 102 | 17 | $74K |
| Donepezil Hcl Generic | 89 | 194 | 23 | $571 |
| Sumatriptan Succinate Generic | 84 | 93 | 24 | $7,712 |
| Rizatriptan Rizatriptan Benzoate | 83 | 97 | 17 | $1,570 |
| Nurtec Odt Rimegepant Sulfate | 83 | 83 | 18 | $112K |
| Kesimpta Pen Ofatumumab | 82 | 82 | Under 11 | $754K |
| Memantine Hcl Generic | 73 | 145 | 20 | $3,049 |
| Butalbital-Acetaminophen-Caffe Butalb/Acetaminophen/Caffeine | 68 | 69 | 14 | $1,464 |
| Primidone Generic | 68 | 158 | 23 | $2,408 |
Brand drugs: 835 claims; generic drugs: 2,719 claims; opioid claims: 74.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Alison C Daigle $7,628 ($7,628 in general payments such as food, travel and fees) from 15 companies. The largest payer was Argenx US, Inc. with $6,344.
| Company | Payments | Amount |
|---|---|---|
| Argenx US, Inc. ARGX | 9 | $6,344 |
| TG Therapeutics, Inc. TGTX | 6 | $278 |
| EMD Serono, Inc. MRK.DE | 5 | $256 |
| Abbvie Inc. ABBV | 17 | $221 |
| Dexcom, Inc. DXCM | 1 | $158 |
| Novartis Pharmaceuticals Corporation NVS | 2 | $75.99 |
| Lundbeck LLC | 3 | $69.95 |
| Genentech, Inc. ROG.SW | 1 | $62.37 |
| Pfizer Inc. PFE | 2 | $42.36 |
| Neurocrine BioSciences, Inc. NBIX | 1 | $24.34 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.